- ICH GCP
- Реестр клинических исследований ЕС
Страница клинических исследований Nct
Clinical Trial Results:
A double-blind, randomised, placebo-controlled, parallel group study to investigate the efficacy, safety, tolerability, pharmacokinetics and pharmacodynamics of SB-497115-GR, a thrombopoietin receptor agonist, administered at 30, 50 and 75 mg as oral tablets once-daily for 6 weeks to adult male and female subjects with refractory, chronic immune thrombocytopenic purpura.
Summary | |
EudraCT number | 2004-000367-98 |
Trial protocol | GB SE DE EE LV IE DK ES |
Global completion date | 31 Jan 2007 |
Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | No |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | No |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | No |
Results information | |
Results version number | v1(current) |
This version publication date | 16 Feb 2016 |
First version publication date | 13 Nov 2014 |
Other versions | |
Summary report(s) | TRA100773-Clinical-Study-Result-Summary |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.